Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge

NCT07453342 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT07453342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07453342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge
Lead sponsor
Peking Union Medical College Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
December 31, 2033
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune-related adverse events